Transforming ovarian cancer care by targeting minimal residual disease.

ABSTRACT: Frontline treatment and resultant cure rates in patients with advanced ovarian cancer have changed little over the past several decades. Here, we outline a multidisciplinary approach aimed at gaining novel therapeutic insights by focusing on the poorly understood minimal residual disease phase of ovarian cancer that leads to eventual incurable recurrences.

SUBMITTER: Jazaeri AA 

PROVIDER: S-EPMC11275633 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature